drugset / Trial / NCT00927732
Hydroquinidine Versus Placebo in Patients With Brugada Syndrome
RandomizedCrossoverQuadruple-blindTreatment
Summary
The specific aim of this study is to determine whether hydroquinidine administration can prevent heart from appearance of ventricular arrhythmia detected by the automatic implantable defibrillator (ICD).
Timeline
- Start
- 2009-02
- Primary completion
- 2014-10
- Completion
- 2014-10
Outcome
Outcome not reported
Stopped (Enrollment): “insufficient recruitment, a lot of premature study discontinuations”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | hydroquinidine | Small molecule | 300 mg | — |